Low HbA1c and mortality: causation and confounding (Q47375082)

15 January 2018

title

Low HbA1c and mortality: causation and confounding (English)

1 reference

15 January 2018

author

Martin Rutter

series ordinal

1

1 reference

15 January 2018

publication date

18 July 2012

1 reference

15 January 2018

published in

Diabetologia

1 reference

15 January 2018

volume

55

1 reference

15 January 2018

issue

9

1 reference

15 January 2018

page(s)

2307-2311

1 reference

15 January 2018

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

cites work

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

A1C and cardiovascular outcomes in type 2 diabetes: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Hypoglycemia and cardiovascular risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2620-3

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22806354

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22806354

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-012-2620-3

1 reference

15 January 2018

1 reference

15 January 2018